Small Molecule Development & Manufacturting at Quotient Sciences

Accelerating Drug Product Optimization using Translational Pharmaceutics

Cambridge, MA, United States | 6 June 2024

Drug product optimization is a critical development step that is common for most drugs that are progressing through today’s development pipelines to respond to suboptimal exposure profiles, to transition from an early development formulation to one suitable for chronic administration in patients, or as part of a life-cycle management strategy. 

Traditional drug product optimization processes take 12-18 months to complete and place significant emphasis on the predictive power of laboratory and preclinical assessments. This approach is a non-optimal working model necessitated by the multiple disciplines required to develop, make and test new formulations in humans. 

In this presentation, Dr. Aruna Railkar, Senior Drug Development Consultant, will describe the application of Quotient Sciences’ Translational Pharmaceutics® to re-engineer and streamline the drug product optimization process, using clinical data to improve decision-making and halve development timelines.

Key learning objectives:

  • Develop an understanding of Translational Pharmaceutics® when applied to drug product optimization 
  • Hear case studies on reformulation programs

Thursday, June 6, 2024

Registration & Networking 11:30 AM-12:00 PM
Seminar/Lunch 12:00-12:45 PM
Q&A/Wrap Up 12:45-1:15 PM

Catalyst Restaurant
300 Technology Square
Cambridge, MA 02139

*We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.

Register now
Catalyst Restaurant
300 Technology Square, Cambridge, MA 02139
Cambridge, MA, United States

Meet our expert:

We look forward to meeting you at our seminar taking place in Cambridge, MA

Dr. Aruna Railkar

Senior Drug Development Consultant

Dr. Aruna Railkar is a Senior Drug Development Consultant. She works in the areas of NCE screening, compound characterization and ...

Contact Us

More insight from our experts:

Read More
Formulation Development, Early Development, Drug Product Optimization, Late Development, Dr. Andrew Lewis Integrated Development Strategies, Part 2: Reformulating for clinical and commercial success By: Dr. Andrew Lewis
Read More
Biopharmaceutics, Early Development, Drug Product Optimization, Formulation Development The Role of Biopharmaceutics in Early Drug Development By: Dr. Vanessa Zann
Read More
Integrated Programs, Drug Substance, Drug Product, Clinical Pharmacology, Candidate Development From Drug Substance to Drug Product to Clinic: Benefits of working with an integrated services provider By: Dr. Paul Quigley
Read More